KML29
KML29 is a potent and selective monoacylglycerol lipase (MAGL) inhibitor, effective across human, mouse, and rat enzymes while showing no activity against FAAH. It selectively elevates brain 2-AG levels in vivo, making it a valuable research tool for studying endocannabinoid signaling in neurological and inflammatory disease models.
Product Specifications
CAS Number
1380424-42-9
Product Name Alternative
LPS, Monoacylglycerol lipase, KML 29, KML29, KML-29, inhibit, Inhibitor, HFIP, MAGL, allodynia, 2-AG
Field of Research
Metabolism Research
Purity
98.16% (May vary between batches)
Solubility
DMSO:50 mg/mL (91.01 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.64 mM)
Smiles
OC (C1CCN (CC1) C (=O) OC (C (F) (F) F) C (F) (F) F) (c1ccc2OCOc2c1) c1ccc2OCOc2c1
Molecular Formula
C24H21F6NO7
Molecular Weight
549.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human EMP1 sgRNA gene knockout kit - Lentiviral human EMP1 sgRNA gene knockout kit (plasmid)
